| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 17.28B | 17.30B | 17.05B | 16.83B | 17.11B | 14.48B |
| Gross Profit | 7.24B | 7.76B | 9.31B | 9.45B | 9.62B | 8.11B |
| EBITDA | 8.92B | 9.12B | 8.67B | 8.89B | 9.07B | 7.61B |
| Net Income | 4.71B | 4.72B | 4.45B | 5.63B | 5.12B | 4.90B |
Balance Sheet | ||||||
| Total Assets | 59.46B | 58.55B | 57.07B | 52.67B | 50.66B | 48.54B |
| Cash, Cash Equivalents and Short-Term Investments | 586.00M | 363.00M | 389.00M | 475.00M | 328.00M | 838.00M |
| Total Debt | 22.52B | 21.84B | 21.37B | 18.89B | 15.89B | 12.91B |
| Total Liabilities | 38.01B | 36.99B | 36.02B | 32.55B | 29.28B | 25.79B |
| Stockholders Equity | 21.45B | 21.57B | 21.05B | 20.12B | 21.38B | 22.74B |
Cash Flow | ||||||
| Free Cash Flow | 3.57B | 3.39B | 3.15B | 3.78B | 3.92B | 4.08B |
| Operating Cash Flow | 7.15B | 7.05B | 6.70B | 6.96B | 6.67B | 6.97B |
| Investing Cash Flow | -3.54B | -3.71B | -3.61B | -3.47B | -2.51B | -2.87B |
| Financing Cash Flow | -3.27B | -3.37B | -3.62B | -3.41B | -4.67B | -3.86B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | C$93.05B | 19.09 | 21.95% | 2.62% | 0.47% | 6.34% | |
74 Outperform | C$105.18B | 29.01 | 8.90% | 0.82% | 1.10% | 8.73% | |
68 Neutral | C$12.99B | 19.57 | 24.05% | 1.58% | -2.20% | 4.64% | |
66 Neutral | C$749.62M | 10.32 | 10.91% | 5.09% | 2.27% | 33.87% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | C$15.90B | 73.02 | 11.18% | 1.75% | -7.84% | -21.07% |